Announcements Trials
Browse Landscape

Phase

Phase 3 5Phase 2 3Phase 1/2 2Phase 4 1

Status

Unknown 1Terminated 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 438Neoplasms 363Breast Neoplasms 260Colorectal Neoplasms 243Neoplasm Metastasis 213Melanoma 209Leukemia, Myeloid, Acute 188Multiple Myeloma 187Pancreatic Neoplasms 181Ovarian Neoplasms 178Recurrence 173Prostatic Neoplasms 161Lymphoma, Non-Hodgkin 142Stomach Neoplasms 133Squamous Cell Carcinoma of Head and Neck 127Lung Neoplasms 125Lymphoma 121Carcinoma, Hepatocellular 117Carcinoma, Renal Cell 102Triple Negative Breast Neoplasms 100Leukemia, Lymphocytic, Chronic, B-Cell 99Glioblastoma 97Leukemia 93Advanced Solid Tumor 92Small Cell Lung Carcinoma 91Lymphoma, Large B-Cell, Diffuse 90Head and Neck Neoplasms 87Advanced Solid Tumors 84Endometrial Neoplasms 79Myelodysplastic Syndromes 78

Interventions

PHY 906 1Calcium Aluminosilicate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × INDUSTRY × Diarrhea × Clear all
NCT01739634 2012-12-03

The Efficacy of CASAD in Patients With Diarrhea Related to Medullary Thyroid Cancer

Salient Pharmaceuticals Incorporated

Phase 1/2 Unknown
10 enrolled

Diarrhea, Carcinoma, Medullary

NCT00036517 2005-06-24

Safety Study of the Chemotherapy Modulator PHY906 in Patients With Advanced Colorectal Cancer

PhytoCeutica

Phase 1/2 Terminated
30 enrolled
Gastrointestinal

Diarrhea, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡